AMIVIB 250 INJECTIONAMIKACIN 250mg. IP + SODIUM CITRATE 2.5w/v IP + METHYLPARABEN 0.18w/v IP + PROPY...

Amivib 250 Injection is used for serious infections caused by susceptible Gram-negative bacteria. Main uses: short-term treatment of serious infections due to susceptible strains of Gram-negative bacteria; bacterial septicemia, including neonatal sepsis; serious infections of the respiratory tract; serious infections of bones and joints and of the central nervous system, including meningitis; serious skin and soft tissue infections.

Common side effects of Amivib 250 Injection include skin rash; drug fever; headache; tingling or numbness (paresthesia); tremor; nausea and vomiting. Get medical help at once if you notice hearing loss, including permanent bilateral deafness, or lasting loss of balance; toxic nephropathy or acute renal failure; muscle weakness, acute muscular paralysis or difficulty in breathing (apnea) from neuromuscular blockade.

Amivib 250 Injection contains Amikacin 250 mg + Sodium Citrate 2.5w/v + Methylparaben 0.18w/v + Propylparaben (Preservative) 0.02w/v. Amivib 250 Injection is given by a doctor or nurse, who decides the dose and how often it is given.

The MRP of Amivib 250 Injection is ₹55 for a pack of 1. For chemists and distributors, the PTR is ₹41.9 and the PTS is ₹37.71.

Amivib 250 Injection contains Amikacin 250 mg + Sodium Citrate 2.5w/v + Methylparaben 0.18w/v + Propylparaben (Preservative) 0.02w/v. It comes in a pack of 1.

Amikacin is an aminoglycoside antibiotic. It binds to the ribosomes of bacteria and stops them from making protein, so susceptible Gram-negative bacteria are killed. Sodium Citrate is present as a formulation component; its exact function in this injection is not described in the supplied product information. Methylparaben and Propylparaben are preservatives; they help keep the injection free from microbial contamination.

Must not be used in patients with a history of hypersensitivity to amikacin. Must not be used in patients with a history of hypersensitivity or serious toxic reactions to other aminoglycosides, because of cross-sensitivity in this class. Check with a doctor first if the patient is pregnant or becomes pregnant during treatment, as aminoglycosides can cross the placenta and cause harm to the fetus. Check with a doctor first if the patient has kidney impairment, as the risk of hearing and kidney damage is higher.

Amivib 250 Injection is a brand of Vibcare Pharma, sold through its Prima division. It is available for PCD pharma franchise and distribution in India; use the Send Enquiry or WhatsApp button on this page to ask about availability and terms.